Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 197
interventional 128
Observational 65
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Biological 29
Biological|placebo 18
Behavioral 12
Drug 12
Device 10
Other 10
Drug|placebo 5
Other|Procedure 4
Procedure 4
Biological|Other 3
Diagnostic Test 3
Biological|Drug 2
Biological|Other|Procedure 2
Device|Drug 2
Dietary Supplement|placebo 2
Drug|Other|Procedure|Radiation 2
Drug|Procedure|Radiation 2
Biological|Drug|placebo 1
Combination Product 1
Device|placebo 1
Dietary Supplement|Other|placebo 1
Drug|Other|Radiation 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 40
NA 31
China 8
Czechia 4
France 4
Spain 4
Canada 3
Kenya 3
Costa Rica 2
United Kingdom 2
United States|Puerto Rico 2
Argentina|France 1
Austria|Belgium|Finland|Germany|Italy|Spain 1
Belgium 1
Belgium|Germany|Netherlands 1
Bolivia 1
Botswana 1
Colombia|Germany|Honduras|Panama|Taiwan 1
Congo, The Democratic Republic of the 1
Cuba 1
Denmark 1
Hong Kong 1
Italy 1
Japan 1
Kenya|Malawi|South Africa|Tanzania|Uganda|Zimbabwe 1
Madagascar 1
Peru 1
Switzerland 1
Taiwan 1
Thailand 1
Uganda 1
United States|Australia 1
United States|Belgium|Colombia|Czechia|France|Israel|Italy|Mexico|Peru|Spain|Taiwan 1
United States|Belgium|United Kingdom 1
United States|Canada 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 85
2 8
3 6
4 6
5 5
6 2
7 4
8 3
9 1
12 1
13 1
17 1
18 1
24 1
28 1
57 1
58 1

Phase

Phase Study_Count
N/A 40
Phase 3 30
Phase 2 29
Phase 1 10
Phase 4 9
Phase 1/Phase 2 6
Early Phase 1 2
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 35
2 59
3 14
4 9
5 5
6 1
10 1
NA 4

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1306 5.00 12.0 24.00000 7.0000 325.00 51.000 19.00
1st Qu. 2479 102.25 20.0 45.75000 50.0000 338.75 269.250 156.00
Median 3652 270.00 48.5 64.50000 84.0000 352.50 1226.500 300.00
Mean 3652 2768.70 53.5 73.83333 259.3103 352.50 2697.867 3283.25
3rd Qu. 4825 1058.75 90.0 69.00000 288.0000 366.25 3057.000 1312.50
Max. 5998 53414.00 98.0 180.00000 1499.0000 380.00 14840.000 22089.00

Trial Group Type

group_type Group_Count
Experimental 168
Active Comparator 39
Placebo Comparator 35
Other 16
No Intervention 14
NA 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 73
Single Group Assignment 40
Sequential Assignment 6
Factorial Assignment 5
Crossover Assignment 2
NA 2

Primary Purpose

primary_purpose Study_Count
Prevention 53
Treatment 44
Screening 12
Health Services Research 7
Diagnostic 6
Basic Science 3
Other 1
Supportive Care 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 23
NA 9
France 5
Belgium 3
Thailand 3
Australia 2
Canada 2
China 2
Bahrain 1
Brazil 1
Costa Rica 1
Denmark 1
Egypt 1
Germany 1
Martinique 1
Netherlands 1
Spain 1
Sweden 1
Switzerland 1
Taiwan 1
Turkey 1
United Kingdom 1
United States|Japan|Korea, Republic of 1
Venezuela 1

Sites per Study

Site_count Study_Count
1 49
2 4
3 5
4 3
5 1
7 1
24 1
161 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 137.000
Median 400.000
Mean 6783.677
3rd Qu 1260.000
Max 189629.000

Observation Model

observational_model Study_Count
Cohort 33
Ecologic or Community 10
NA 10
Case-Control 3
Case-Only 3
Case Control 3
Other 3

Time Perspective

time_perspective Study_Count
Prospective 42
Cross-Sectional 8
Retrospective 8
Other 4
NA 3

Registries

Studies by Country

Country Study_Count
China 2
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 2
9 1
44 1

Enrollment Metrics

Measure Registries
Min 151.00
1st Qu 217.75
Median 270.00
Mean 272.75
3rd Qu 325.00
Max 400.00

Registry Model

observational_model Study_Count
Cohort 2
Case-Control 1
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 4

Follow-up

target_duration Study_Count
3 Years 2
1 Year 1
32 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04199689 Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) https://ClinicalTrials.gov/show/NCT04199689 Recruiting Merck Sharp & Dohme Corp. 2024-07-15
NCT04015336 E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT04015336 Recruiting National Institutes of Health Clinical Center (CC) 2023-04-28
NCT04133610 HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs https://ClinicalTrials.gov/show/NCT04133610 Completed The Institute of Molecular and Translational Medicine, Czech Republic 2019-10-30
NCT03302858 A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand https://ClinicalTrials.gov/show/NCT03302858 Recruiting Laser Surgery Care 2019-10-31
NCT03284866 HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV https://ClinicalTrials.gov/show/NCT03284866 Active, not recruiting AIDS Malignancy Consortium 2022-01-31
NCT03202992 Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection https://ClinicalTrials.gov/show/NCT03202992 Completed Antiva Biosciences 2019-02-04
NCT03180034 Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines https://ClinicalTrials.gov/show/NCT03180034 Active, not recruiting National Institutes of Health Clinical Center (CC) 2022-12-31
NCT03158220 Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) https://ClinicalTrials.gov/show/NCT03158220 Completed Merck Sharp & Dohme Corp. 2018-11-19
NCT03085381 A Phase I Study of Quadrivalent HPV Recombinant Vaccine https://ClinicalTrials.gov/show/NCT03085381 Completed Shanghai Bovax Biotechnology Co., Ltd. 2017-10-31
NCT03032575 Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection https://ClinicalTrials.gov/show/NCT03032575 Recruiting Thai Red Cross AIDS Research Centre 2020-12-31
NCT02862795 Human Papillomavirus Anal Infection https://ClinicalTrials.gov/show/NCT02862795 Completed Centre Hospitalier Universitaire de Besancon 2016-06-30
NCT02845739 PApillomavirus in REnal Transplant Patient https://ClinicalTrials.gov/show/NCT02845739 Completed Centre Hospitalier Universitaire de Besancon 2017-11-10
NCT02827838 Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer https://ClinicalTrials.gov/show/NCT02827838 Recruiting Wake Forest University Health Sciences 2020-08-31
NCT02816879 Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT02816879 Active, not recruiting Jonsson Comprehensive Cancer Center 2020-07-31
NCT02811367 The HPV Self-test as a Test of Cure in Madagascar https://ClinicalTrials.gov/show/NCT02811367 Completed University Hospital, Geneva 2016-09-30
NCT02785289 A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection https://ClinicalTrials.gov/show/NCT02785289 Completed University Hospital, Geneva 2016-09-30
NCT02774538 Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort https://ClinicalTrials.gov/show/NCT02774538 Recruiting Institut de Cancérologie de Lorraine 2021-05-31
NCT02733068 A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. https://ClinicalTrials.gov/show/NCT02733068 Active, not recruiting Shanghai Zerun Biotechnology Co.,Ltd 2018-12-31
NCT02632344 Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement https://ClinicalTrials.gov/show/NCT02632344 Active, not recruiting Massachusetts General Hospital 2020-10-31
NCT02592902 Recurrent Respiratory Papillomatosis and Extraesophageal Reflux https://ClinicalTrials.gov/show/NCT02592902 Completed University Hospital Ostrava 2018-08-31
NCT02576054 Safety and Tolerability Study of V501 in Japanese Boys (V501-200) https://ClinicalTrials.gov/show/NCT02576054 Completed Merck Sharp & Dohme Corp. 2018-08-08
NCT02558803 HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 https://ClinicalTrials.gov/show/NCT02558803 Completed Regenstrief Institute, Inc. 2016-05-31
NCT02858310 E7 TCR T Cells for Human Papillomavirus-Associated Cancers https://ClinicalTrials.gov/show/NCT02858310 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT03391921 Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) https://ClinicalTrials.gov/show/NCT03391921 Recruiting Centre Hospitalier Universitaire Saint Pierre 2020-01-08
NCT02551887 HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts https://ClinicalTrials.gov/show/NCT02551887 Completed Regenstrief Institute, Inc. 2015-04-30
NCT02546752 Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine https://ClinicalTrials.gov/show/NCT02546752 Completed Regenstrief Institute, Inc. 2016-05-31
NCT02535104 Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) https://ClinicalTrials.gov/show/NCT02535104 Completed Tamir Biotechnology, Inc. 2016-09-30
NCT02464358 An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women https://ClinicalTrials.gov/show/NCT02464358 Completed University of Connecticut 2012-10-31
NCT02460237 HPV Self-Test Intervention in Ohio Appalachia https://ClinicalTrials.gov/show/NCT02460237 Completed Ohio State University Comprehensive Cancer Center 2016-06-14
NCT02405533 Phase II Evaluation of AHCC for the Eradication of HPV Infections https://ClinicalTrials.gov/show/NCT02405533 Active, not recruiting The University of Texas Health Science Center, Houston 2019-02-28
NCT02354144 Lubricant Investigation in Men to Inhibit Transmission of HPV Infection https://ClinicalTrials.gov/show/NCT02354144 Recruiting McGill University 2020-10-31
NCT02346227 Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix https://ClinicalTrials.gov/show/NCT02346227 Completed Universiteit Antwerpen 2018-08-31
NCT02304770 Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia https://ClinicalTrials.gov/show/NCT02304770 Completed Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 2017-01-31
NCT02287961 Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT02287961 Active, not recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2021-06-30
NCT02263378 A New Supplement for the Immune Response to HPV Infection https://ClinicalTrials.gov/show/NCT02263378 Completed University of Messina 2016-03-31
NCT02258659 Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT02258659 Active, not recruiting University of Chicago 2018-12-31
NCT02124252 Community-Driven Cervical Cancer Prevention in Western Kenya https://ClinicalTrials.gov/show/NCT02124252 Completed Duke University 2016-10-31
NCT02114385 A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) https://ClinicalTrials.gov/show/NCT02114385 Completed Merck Sharp & Dohme Corp. 2015-04-22
NCT02067507 Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County https://ClinicalTrials.gov/show/NCT02067507 Completed University of California, Los Angeles 2019-10-31
NCT02065973 An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 https://ClinicalTrials.gov/show/NCT02065973 Completed PDS Biotechnology Corp. 2015-12-30
NCT02048020 Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer https://ClinicalTrials.gov/show/NCT02048020 Completed Jonsson Comprehensive Cancer Center 2017-01-09
NCT03929172 A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects https://ClinicalTrials.gov/show/NCT03929172 Completed 2A Pharma AB 2020-05-29
NCT02009800 ICI-VPH: Impact of HPV Immunisation Schedules Against HPV https://ClinicalTrials.gov/show/NCT02009800 Active, not recruiting CHU de Quebec-Universite Laval 2021-12-31
NCT01984697 A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010) https://ClinicalTrials.gov/show/NCT01984697 Completed Merck Sharp & Dohme Corp. 2015-06-19
NCT01946139 Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV https://ClinicalTrials.gov/show/NCT01946139 Completed AIDS Malignancy Consortium 2018-10-31
NCT01932697 Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT01932697 Active, not recruiting Mayo Clinic 2016-10-20
NCT01924117 Genotypification and Predisposing Factors in Human Papilloma Virus Infection https://ClinicalTrials.gov/show/NCT01924117 Completed Materno-Perinatal Hospital of the State of Mexico 2011-05-31
NCT01901770 The Parents in Appalachia Receive Education Needed for Teen Project https://ClinicalTrials.gov/show/NCT01901770 Active, not recruiting Ohio State University Comprehensive Cancer Center 2020-12-31
NCT01898494 Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT01898494 Active, not recruiting Eastern Cooperative Oncology Group 2020-02-29
NCT01862874 Efficacy and Tolerability Study of V501 in Japanese Males (V501-122) https://ClinicalTrials.gov/show/NCT01862874 Completed Merck Sharp & Dohme Corp. 2017-08-30
NCT01824992 Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections https://ClinicalTrials.gov/show/NCT01824992 Completed Lee’s Pharmaceutical Limited 2012-03-31
NCT01824537 Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study https://ClinicalTrials.gov/show/NCT01824537 Recruiting McGill University 2020-09-30
NCT01693783 Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer https://ClinicalTrials.gov/show/NCT01693783 Active, not recruiting National Cancer Institute (NCI) 2020-12-31
NCT01588301 Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention https://ClinicalTrials.gov/show/NCT01588301 Completed University Hospital, Tours 2012-12-31
NCT01571141 Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection https://ClinicalTrials.gov/show/NCT01571141 Completed AGUNCO Obstetrics and Gynecology Centre NA
NCT01550783 Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening https://ClinicalTrials.gov/show/NCT01550783 Completed University of Washington 2017-11-16
NCT01532102 Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts https://ClinicalTrials.gov/show/NCT01532102 Completed Vaxart 2013-05-06
NCT01492582 Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors https://ClinicalTrials.gov/show/NCT01492582 Active, not recruiting University of Alabama at Birmingham 2019-02-08
NCT01375868 Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT01375868 Completed Institute of Hematology and Blood Transfusion, Czech Republic 2018-12-31
NCT04438291 Effects of a HPV Vaccination Health-promotion Programme on Improving Vaccine Acceptance and Uptake Among Female Adolescents https://ClinicalTrials.gov/show/NCT04438291 Recruiting Chinese University of Hong Kong 2022-01-31
NCT04436133 Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) https://ClinicalTrials.gov/show/NCT04436133 Recruiting National Vaccine and Serum Institute, China 2021-01-22
NCT04398433 INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) https://ClinicalTrials.gov/show/NCT04398433 Recruiting Inovio Pharmaceuticals 2023-07-31
NCT04333212 HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix https://ClinicalTrials.gov/show/NCT04333212 Completed Chang Gung Memorial Hospital 2013-12-30
NCT04278326 Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments https://ClinicalTrials.gov/show/NCT04278326 Recruiting Centre Hospitalier Régional d’Orléans 2024-04-30
NCT04270773 Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women https://ClinicalTrials.gov/show/NCT04270773 Recruiting University Hospital Virgen de las Nieves 2022-07-30
NCT04247282 Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection https://ClinicalTrials.gov/show/NCT04247282 Recruiting National Institutes of Health Clinical Center (CC) 2022-08-31
NCT04226313 Self-sampling for Non-attenders to Cervical Cancer Screening https://ClinicalTrials.gov/show/NCT04226313 Recruiting The Institute of Molecular and Translational Medicine, Czech Republic 2020-12-01
NCT04210336 Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV https://ClinicalTrials.gov/show/NCT04210336 Recruiting Procare Health Iberia S.L. 2020-08-31
NCT04199078 Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. https://ClinicalTrials.gov/show/NCT04199078 Recruiting Procare Health Iberia S.L. 2020-06-30
NCT04191967 Thermocoagulation for Treatment of Precancerous Cervical Lesions https://ClinicalTrials.gov/show/NCT04191967 Recruiting University of California, San Francisco 2020-12-31
NCT04124198 Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT04124198 Recruiting Rigshospitalet, Denmark 2024-01-31
NCT04083196 A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years https://ClinicalTrials.gov/show/NCT04083196 Recruiting National Vaccine and Serum Institute, China 2021-03-12
NCT04072913 Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix https://ClinicalTrials.gov/show/NCT04072913 Completed University Hospital, Bordeaux 2011-01-31
NCT04002154 Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV https://ClinicalTrials.gov/show/NCT04002154 Completed Procare Health Iberia S.L. 2018-07-31
NCT04000503 Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) https://ClinicalTrials.gov/show/NCT04000503 Recruiting University of British Columbia 2021-12-31
NCT03998254 Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) https://ClinicalTrials.gov/show/NCT03998254 Active, not recruiting Merck Sharp & Dohme Corp. 2027-02-01
NCT03981822 A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts https://ClinicalTrials.gov/show/NCT03981822 Recruiting Verrica Pharmaceuticals Inc. 2020-08-12
NCT03903562 Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024) https://ClinicalTrials.gov/show/NCT03903562 Active, not recruiting Merck Sharp & Dohme Corp. 2020-07-31
NCT03900572 A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine https://ClinicalTrials.gov/show/NCT03900572 Recruiting Shanghai Zerun Biotechnology Co.,Ltd 2020-04-30
NCT03898167 Prospective Evaluation of Self-Testing to Increase Screening https://ClinicalTrials.gov/show/NCT03898167 Enrolling by invitation Baylor College of Medicine 2023-02-28
NCT03726151 Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs https://ClinicalTrials.gov/show/NCT03726151 Enrolling by invitation University of California, Los Angeles 2022-10-31
NCT03346915 Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention https://ClinicalTrials.gov/show/NCT03346915 Completed Boston Medical Center 2019-04-19
NCT03707587 M7824 in People With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT03707587 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-07-07
NCT03675256 The KEN SHE Study on HPV-vaccine Efficacy https://ClinicalTrials.gov/show/NCT03675256 Active, not recruiting University of Washington 2022-11-15
NCT03610581 Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix https://ClinicalTrials.gov/show/NCT03610581 Recruiting Janssen Vaccines & Prevention B.V. 2020-08-09
NCT03584308 Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal https://ClinicalTrials.gov/show/NCT03584308 Completed Catalysis SL 2018-05-15
NCT03546842 Safety and Immunogenicity Study of V503 (GARDASILâ„¢9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) https://ClinicalTrials.gov/show/NCT03546842 Completed Merck Sharp & Dohme Corp. 2019-01-29
NCT03510091 Video-Assisted Counseling for HPV Vaccination https://ClinicalTrials.gov/show/NCT03510091 Recruiting Le Bonheur Children’s Hospital 2018-11-30
NCT03487549 Cantharidin and Occlusion in Verruca Epithelium https://ClinicalTrials.gov/show/NCT03487549 Completed Verrica Pharmaceuticals Inc. 2019-05-16
NCT03442062 Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination https://ClinicalTrials.gov/show/NCT03442062 Completed University of North Carolina, Chapel Hill 2020-04-30
NCT01254643 A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). https://ClinicalTrials.gov/show/NCT01254643 Completed Merck Sharp & Dohme Corp. 2013-08-10
NCT01245764 GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046) https://ClinicalTrials.gov/show/NCT01245764 Completed Merck Sharp & Dohme Corp. 2013-04-15
NCT01104181 Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test https://ClinicalTrials.gov/show/NCT01104181 Completed Laser Surgery Care 2010-12-31
NCT01073293 A Study of V503 Vaccine Given Concomitantly With REPEVAXâ„¢ in 11 to 15 Year Olds (V503-007) https://ClinicalTrials.gov/show/NCT01073293 Completed Merck Sharp & Dohme Corp. 2011-06-16
NCT01020747 Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) https://ClinicalTrials.gov/show/NCT01020747 Completed Massachusetts General Hospital 2011-03-31
NCT00988884 A Study of V503 Given Concomitantly With Menactraâ„¢ and Adacelâ„¢ in 11 to 15 Year Olds (V503-005) https://ClinicalTrials.gov/show/NCT00988884 Completed Merck Sharp & Dohme Corp. 2011-02-22
NCT00973856 Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands https://ClinicalTrials.gov/show/NCT00973856 Completed Akron General Medical Center 2011-12-31
NCT00973362 Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System https://ClinicalTrials.gov/show/NCT00973362 Completed Gen-Probe, Incorporated 2013-06-30
NCT00956553 Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls https://ClinicalTrials.gov/show/NCT00956553 Completed Public Health England 2012-09-30
NCT00943722 A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) https://ClinicalTrials.gov/show/NCT00943722 Active, not recruiting Merck Sharp & Dohme Corp. 2011-04-30
NCT00925288 Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers https://ClinicalTrials.gov/show/NCT00925288 Completed Johns Hopkins Bloomberg School of Public Health 2011-08-31
NCT04369339 Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology https://ClinicalTrials.gov/show/NCT04369339 Completed Bezmialem Vakif University 2019-10-01
NCT03345875 Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana https://ClinicalTrials.gov/show/NCT03345875 Completed Jhpiego 2018-06-30
NCT00834106 Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) https://ClinicalTrials.gov/show/NCT00834106 Completed Merck Sharp & Dohme Corp. 2012-05-11
NCT02631863 Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) https://ClinicalTrials.gov/show/NCT02631863 Completed Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 2018-11-24
NCT02859454 Avelumab for People With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT02859454 Active, not recruiting National Institutes of Health Clinical Center (CC) 2018-06-30
NCT00685412 Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 https://ClinicalTrials.gov/show/NCT00685412 Completed Inovio Pharmaceuticals 2011-01-31
NCT00635830 An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) https://ClinicalTrials.gov/show/NCT00635830 Completed Merck Sharp & Dohme Corp. 2008-04-30
NCT00572832 Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting https://ClinicalTrials.gov/show/NCT00572832 Completed University of Pittsburgh 2009-04-30
NCT00571701 Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT00571701 Completed Northwell Health 2015-01-31
NCT00551187 A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) https://ClinicalTrials.gov/show/NCT00551187 Completed Merck Sharp & Dohme Corp. 2009-05-31
NCT00543543 Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) https://ClinicalTrials.gov/show/NCT00543543 Completed Merck Sharp & Dohme Corp. 2013-04-10
NCT00520598 Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) https://ClinicalTrials.gov/show/NCT00520598 Completed Merck Sharp & Dohme Corp. 2011-05-31
NCT00518180 A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents https://ClinicalTrials.gov/show/NCT00518180 Completed Novartis 2008-04-30
NCT00496626 An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) https://ClinicalTrials.gov/show/NCT00496626 Completed Merck Sharp & Dohme Corp. 2009-02-28
NCT00411749 V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028) https://ClinicalTrials.gov/show/NCT00411749 Completed Merck Sharp & Dohme Corp. 2009-09-18
NCT00380367 Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029) https://ClinicalTrials.gov/show/NCT00380367 Completed Merck Sharp & Dohme Corp. 2008-02-04
NCT00378560 V501 Efficacy Study in Women Aged 18 to 26 (V501-027) https://ClinicalTrials.gov/show/NCT00378560 Completed Merck Sharp & Dohme Corp. 2009-09-16
NCT00365716 Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED) https://ClinicalTrials.gov/show/NCT00365716 Completed Merck Sharp & Dohme Corp. 2004-05-31
NCT00316706 Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals’ (GSK Bio) HPV-16/18 Vaccine https://ClinicalTrials.gov/show/NCT00316706 Completed GlaxoSmithKline 2009-01-31
NCT00303823 Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia https://ClinicalTrials.gov/show/NCT00303823 Completed National Cancer Institute (NCI) 2010-11-30
NCT00205374 Use of Cidofovir for Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT00205374 Completed University of Wisconsin, Madison 2009-12-31
NCT00157950 Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) https://ClinicalTrials.gov/show/NCT00157950 Completed Merck Sharp & Dohme Corp. 2006-06-30
NCT00092547 A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) https://ClinicalTrials.gov/show/NCT00092547 Completed Merck Sharp & Dohme Corp. 2005-11-03
NCT00090220 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) https://ClinicalTrials.gov/show/NCT00090220 Completed Merck Sharp & Dohme Corp. 2009-05-21
NCT00054041 Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia https://ClinicalTrials.gov/show/NCT00054041 Completed National Cancer Institute (NCI) 2007-01-31
NCT00038714 A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT00038714 Completed Nventa Biopharmaceuticals Corporation NA
NCT00000764 Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. https://ClinicalTrials.gov/show/NCT00000764 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03265743 HPV Vaccination in Women With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03265743 Completed Hospices Civils de Lyon 2017-12-15
NCT03082950 HPV Infections, Cancer of the Vulva and Therapeutical Success https://ClinicalTrials.gov/show/NCT03082950 Completed University of Luebeck 2017-12-31
NCT03000933 Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2) https://ClinicalTrials.gov/show/NCT03000933 Active, not recruiting The Alfred 2019-12-31
NCT02897427 HPV-related Oropharyngeal and Uncommon Cancers Screening https://ClinicalTrials.gov/show/NCT02897427 Recruiting M.D. Anderson Cancer Center 2027-03-28
NCT02897232 Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination https://ClinicalTrials.gov/show/NCT02897232 Active, not recruiting Louisiana State University Health Sciences Center Shreveport 2017-03-31
NCT02809352 Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer https://ClinicalTrials.gov/show/NCT02809352 Completed CHU de Reims 2014-12-31
NCT02714114 Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study) https://ClinicalTrials.gov/show/NCT02714114 Completed Universiteit Antwerpen 2015-12-31
NCT02653118 Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) https://ClinicalTrials.gov/show/NCT02653118 Active, not recruiting Merck Sharp & Dohme Corp. 2024-01-01
NCT02634190 Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens https://ClinicalTrials.gov/show/NCT02634190 Active, not recruiting Hologic Deutschland GmbH 2023-04-30
NCT00786760 Natural History of HPV Infection in Men: The HIM Study https://ClinicalTrials.gov/show/NCT00786760 Completed H. Lee Moffitt Cancer Center and Research Institute 2012-12-31
NCT02376478 On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection https://ClinicalTrials.gov/show/NCT02376478 Completed Medical University of Vienna 2011-01-31
NCT02355262 CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers https://ClinicalTrials.gov/show/NCT02355262 Active, not recruiting OHSU Knight Cancer Institute 2020-06-30
NCT02188004 The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases https://ClinicalTrials.gov/show/NCT02188004 Completed Xiamen University 2016-05-31
NCT01295242 Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM) https://ClinicalTrials.gov/show/NCT01295242 Completed University of Washington 2012-08-31
NCT01894425 Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation https://ClinicalTrials.gov/show/NCT01894425 Completed Centre Hospitalier Universitaire de Nīmes 2016-10-23
NCT01788852 HPV in Adolescents https://ClinicalTrials.gov/show/NCT01788852 Completed The HIV Netherlands Australia Thailand Research Collaboration 2012-12-31
NCT01717443 Genital HPV Infections Before and After Renal Transplantation https://ClinicalTrials.gov/show/NCT01717443 Completed University Medical Center Nijmegen 2015-10-31
NCT01702337 Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine https://ClinicalTrials.gov/show/NCT01702337 Completed GlaxoSmithKline 2010-02-28
NCT01694875 Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System https://ClinicalTrials.gov/show/NCT01694875 Completed Gen-Probe, Incorporated 2012-11-30
NCT01567813 Post-Licensure Study of the Safety of GARDASILâ„¢ in Males (V501-070) https://ClinicalTrials.gov/show/NCT01567813 Completed Merck Sharp & Dohme Corp. 2019-06-01
NCT01492842 Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV https://ClinicalTrials.gov/show/NCT01492842 Completed University of North Carolina, Chapel Hill 2012-06-30
NCT01446198 Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System https://ClinicalTrials.gov/show/NCT01446198 Completed Gen-Probe, Incorporated 2012-05-31
NCT01384370 APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results https://ClinicalTrials.gov/show/NCT01384370 Completed Gen-Probe, Incorporated 2011-08-31
NCT04391647 Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples https://ClinicalTrials.gov/show/NCT04391647 Recruiting Universiteit Antwerpen 2020-07-31
NCT04171505 Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. https://ClinicalTrials.gov/show/NCT04171505 Recruiting Hospital San Carlos, Madrid 2019-11-04
NCT04167501 Impact of HPV Vaccination on Cervical High Grade Lesions in France https://ClinicalTrials.gov/show/NCT04167501 Recruiting Centre Hospitalier Universitaire de Besancon 2020-08-31
NCT04155294 Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV https://ClinicalTrials.gov/show/NCT04155294 Recruiting University of Oxford 2021-03-31
NCT04117386 Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium https://ClinicalTrials.gov/show/NCT04117386 Recruiting Chulalongkorn University 2020-05-31
NCT04057924 Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN https://ClinicalTrials.gov/show/NCT04057924 Recruiting University Hospital, Bordeaux 2029-09-01
NCT03961178 A Cohort Study for the Following up of Conization https://ClinicalTrials.gov/show/NCT03961178 Recruiting Peking Union Medical College Hospital 2021-05-22
NCT03888599 Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination https://ClinicalTrials.gov/show/NCT03888599 Completed University Hospital, Geneva 2019-06-01
NCT03837028 The Human Papilloma Virus Effect on Sexual Life https://ClinicalTrials.gov/show/NCT03837028 Completed Bakirkoy Dr. Sadi Konuk Research and Training Hospital 2018-06-01
NCT03638427 Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood https://ClinicalTrials.gov/show/NCT03638427 Enrolling by invitation Stanford University 2020-10-01
NCT03542227 Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine https://ClinicalTrials.gov/show/NCT03542227 Active, not recruiting Universiteit Antwerpen 2020-12-15
NCT03474211 Prevalence of HPV Infection Using Self-sampling https://ClinicalTrials.gov/show/NCT03474211 Completed University Hospital, Geneva 2017-01-31
NCT01265212 Prevalence of Human Papillomavirus in Men Living in the Northern Plains https://ClinicalTrials.gov/show/NCT01265212 Completed Sanford Health 2013-09-30
NCT01226368 Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana. https://ClinicalTrials.gov/show/NCT01226368 Completed University Hospital Center of Martinique 2011-01-31
NCT01205412 An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain https://ClinicalTrials.gov/show/NCT01205412 Completed GlaxoSmithKline 2011-11-30
NCT01158209 An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt https://ClinicalTrials.gov/show/NCT01158209 Completed GlaxoSmithKline 2011-08-31
NCT01101828 Self-collected Swabs for HPV Testing in 18-24 Year Old Women https://ClinicalTrials.gov/show/NCT01101828 Completed University of Washington 2011-01-31
NCT01086709 Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191 https://ClinicalTrials.gov/show/NCT01086709 Completed National Institutes of Health Clinical Center (CC) NA
NCT01078220 Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASILâ„¢ (V501-031) https://ClinicalTrials.gov/show/NCT01078220 Completed Merck Sharp & Dohme Corp. 2010-12-13
NCT01077856 GARDASILâ„¢ Vaccine Impact in Population Study (V501-033) https://ClinicalTrials.gov/show/NCT01077856 Completed Merck Sharp & Dohme Corp. 2014-12-02
NCT01030562 Immunogenicity of Off-Schedule Dosing of HPV Vaccine https://ClinicalTrials.gov/show/NCT01030562 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2014-03-05
NCT00937547 Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela https://ClinicalTrials.gov/show/NCT00937547 Completed Instituto Oncologico Luis Razetti 2011-07-31
NCT00933140 Anal HPV Infection and Abnormal Cytology in HIV-infected Women https://ClinicalTrials.gov/show/NCT00933140 Completed Boston Medical Center 2009-09-30
NCT00932009 Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men https://ClinicalTrials.gov/show/NCT00932009 Completed Danish Cancer Society 2009-08-31
NCT00931190 Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia https://ClinicalTrials.gov/show/NCT00931190 Completed Lund University NA
NCT00919997 Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT00919997 Completed AIDS Malignancy Consortium 2010-07-31
NCT00892866 CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells https://ClinicalTrials.gov/show/NCT00892866 Recruiting Gynecologic Oncology Group 2025-05-31
NCT00847340 Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population https://ClinicalTrials.gov/show/NCT00847340 Completed La Fundacion para la Investigacion y el Desarrollo 2010-09-30
NCT04297670 HPV Prevalence in 16-20 Year Old Males https://ClinicalTrials.gov/show/NCT04297670 Recruiting Laval University 2020-12-31
NCT00828555 Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting https://ClinicalTrials.gov/show/NCT00828555 Completed Duke University 2009-04-30
NCT00823511 The Human Papillomavirus (HPV) Transmission Pilot Study https://ClinicalTrials.gov/show/NCT00823511 Completed H. Lee Moffitt Cancer Center and Research Institute 2012-01-31
NCT02003508 Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination https://ClinicalTrials.gov/show/NCT02003508 Completed The Alfred 2017-12-29
NCT01539668 Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas https://ClinicalTrials.gov/show/NCT01539668 Completed Barretos Cancer Hospital 2012-12-31
NCT01792973 HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study https://ClinicalTrials.gov/show/NCT01792973 Completed Institut de Recherche pour le Developpement 2016-12-31
NCT00743392 HPV Infections in Older Women https://ClinicalTrials.gov/show/NCT00743392 Completed University of Washington 2011-05-31
NCT00711815 A Study to Identify Markers in Blood and Tissue of HPV Clearance https://ClinicalTrials.gov/show/NCT00711815 Completed University of Alabama at Birmingham 2010-11-30
NCT00550914 Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP https://ClinicalTrials.gov/show/NCT00550914 Completed Massachusetts Eye and Ear Infirmary NA
NCT00549250 Human Papillomavirus 6/11 in the Lower Airway of Neonates https://ClinicalTrials.gov/show/NCT00549250 Completed National Taiwan University Hospital 2008-06-30
NCT00508170 Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection https://ClinicalTrials.gov/show/NCT00508170 Completed M.D. Anderson Cancer Center 2010-01-31
NCT00461877 High-Risk HPV Infections in Women Aged 25 to 65 https://ClinicalTrials.gov/show/NCT00461877 Completed University of Washington 2008-12-31
NCT00194311 Human Papillomavirus (HPV) Infection in Pregnancy https://ClinicalTrials.gov/show/NCT00194311 Completed University of Pennsylvania 2007-08-31
NCT00188292 Screening for HIV-Associated Anal Cancer https://ClinicalTrials.gov/show/NCT00188292 Completed University Health Network, Toronto 2012-06-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04199260 Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV. https://ClinicalTrials.gov/show/NCT04199260 Recruiting Procare Health Iberia S.L. 2019-12-31
NCT03895866 Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota https://ClinicalTrials.gov/show/NCT03895866 Recruiting Peking Union Medical College Hospital 2020-02-11
NCT03548740 Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection https://ClinicalTrials.gov/show/NCT03548740 Recruiting Peking Union Medical College Hospital 2020-01-20
NCT03465280 Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) https://ClinicalTrials.gov/show/NCT03465280 Recruiting Newcastle-upon-Tyne Hospitals NHS Trust 2020-08-31